Publications by authors named "Doug Altman"

Claim this Profile
E
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].
David E Neal, Chris Metcalfe, Jenny L Donovan, J Athene Lane, Michael Davis, Doug G Altman

Eur Urol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
David E Neal, Chris Metcalfe, Jenny L Donovan, J Athene Lane, Michael Davis, Doug G Altman

Eur Urol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donald Mainland: anatomist, educator, thinker, medical statistician, trialist, rheumatologist.
Doug Altman

J R Soc Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.
William Sones, Steven A Julious, Joanne C Rothwell, Craig Robert Ramsay, Lisa V Hampson, Doug Altman

Trials· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year costs from a randomised comparison of bilateral and single internal thoracic artery grafts.
Matthew Little, Alastair Gray, Doug Altman, Umberto Benedetto, Marcus Flather

Heart· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoping review on interventions to improve adherence to reporting guidelines in health research.
David Blanco, Doug Altman, David Moher, Isabelle Boutron, Jamie J Kirkham

BMJ Open· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt, Doug Altman

Trials· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELTA guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.
Jonathan A Cook, Steven A Julious, William Sones, Lisa V Hampson, Catherine Hewitt, Doug Altman

BMJ· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA guidance.
William Sones, Steven A Julious, Joanne C Rothwell, Craig Robert Ramsay, Lisa V Hampson, Doug Altman

Trials· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.
Melanie Calvert, Derek Kyte, Rebecca Mercieca-Bebber, Anita Slade, An-Wen Chan, Doug Altman

JAMA· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaching consensus on reporting patient and public involvement (PPI) in research: methods and lessons learned from the development of reporting guidelines.
Jo Brett, Sophie Staniszewska, Iveta Simera, Kate Seers, Carole Mockford, Doug Altman

BMJ Open· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protocol of a cross-sectional study evaluating an online tool for early career peer reviewers assessing reports of randomised controlled trials.
Anthony Chauvin, David Moher, Doug Altman, David L Schriger, Sabina Alam

BMJ Open· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA guidance protocol.
Jonathan A Cook, Steven A Julious, William Sones, Joanne C Rothwell, Craig R Ramsay, Doug Altman

Trials· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Methods for evaluating medical tests and biomarkers.
Gowri Gopalakrishna, Miranda Langendam, Rob Scholten, Patrick Bossuyt, Mariska Leeflang, Doug Altman, Doug Altman, Doug Altman, Doug G Altman, Douglas G Altman, Doug Altman, Douglas G Altman, Douglas Altman, Douglas G Altman

Diagn Progn Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings.
Rolf H H Groenwold, Karel G M Moons, Romin Pajouheshnia, Doug G Altman, Gary S Collins

J Clin Epidemiol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges.
Richard D Riley, Joie Ensor, Kym I E Snell, Thomas P A Debray, Doug G Altman

BMJ· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abstracts of the 4th Meeting of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative.
Elizabeth Gargon, Doug G Altman, Jane M Blazeby, Mike Clarke, Paula R Williamson

Trials· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 5th Meeting of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative.
Sarah L Gorst, Doug G Altman, Jane M Blazeby, Mike Clarke, Elizabeth Gargon

Trials· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The need for consensus, consistency, and core outcome sets in perioperative research.
Jane M Blazeby, Paula R Williamson, Doug Altman

Can J Anaesth· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The COMET initiative database: progress and activities update (2014).
Elizabeth Gargon, Paula R Williamson, Doug G Altman, Jane M Blazeby, Mike Clarke

Trials· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of analysis methods for diagnostic imaging tests: problems with ROC AUC and confidence scores in CT colonography.
Susan Mallett, Steve Halligan, Gary S Collins, Doug G Altman

PLoS One· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform.
Shaun Treweek, Doug G Altman, Peter Bower, Marion Campbell, Iain Chalmers

Trials· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the use of an expertise-based randomised controlled trial design.
Jonathan A Cook, Andrew Elders, Charles Boachie, Ted Bassinga, Cynthia Fraser, Doug G Altman

Trials· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The distribution of clinical phenotypes of preterm birth syndrome: implications for prevention.
Fernando C Barros, Aris T Papageorghiou, Cesar G Victora, Julia A Noble, Ruyan Pang, Doug G Altman

JAMA Pediatr· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis